Skip to main content
Premium Trial:

Request an Annual Quote

GCI, AnVil To Probe Arthritis Gene Expression

NEW YORK, April 24-AnVil and Genomics Collaborative will be working together on a pilot project to apply new data analysis and visualization systems to microarray data, AnVil said in a statement today.

In the project, AnVil will apply its visualization and analysis tools to GCI's DNA microarray data.

The partnership is designed to help GCI identify gene expression patterns that could suggest new drug targets for inflammatory disease, especially rheumatoid arthritis.

AnVil, based in Burlington, Mass., is a privately held bioinformatics company.

GCI is a functional genomics company that has developed a large-scale database of linked clinical data, including DNA, sera, tissue samples and patient information.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.